Advinus Therapeutics and P2D Bioscience Enter Into a Research and Development Collaboration for Attention Deficit Hyperactivity Disorder (ADHD)
24. Juli 2012 08:35 ET | P2D Bioscience
CINCINNATI, OH and BANGALORE, INDIA--(Marketwire - Jul 24, 2012) -  Advinus Therapeutics Ltd., a drug discovery and development company, and P2D Bioscience, a CNS-focused specialty...